Propionate content was lower on the skin surface of AD patients. Topical application of propionate attenuated skin inflammation in mice by inhibiting IL‐33 production in keratinocytes and improved the symptoms of AD patients. This evidence concerns the gene IL33 and Alzheimer disease.